Re cently, Walker and Young (1997) re porte d that ultraviolet (UV) B sunscreens offer the same UVB protection factors against inflammation and immunosuppression in the mouse . The authors studied th e relationship between photo protection of inflammation and immunosuppress ion with monochromatic (Philips TL-01 tubes, A..,. _ ,= 311mll) UVB radiation. T he UVB dose-response curve for murine ed ema was similar to that for human erythema . T he protection afford ed by the UVB fi lters, octyl dimethyl paraaminobenzoic acid and 2-ethylhexyl-4'-methoxycinnamate (2-EHMC), rev ealed that topical or tape application of sunscreen protected totally agai11 st UV-induced inflammation but onJy parti ail y against UV-indu ced immunosuppressio n. Furthermore, a sun protection factor (SPF) of 4, i11 vi 11o, was determined for 2-EHMC for both inflammation and immunosuppression.
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These fu1d ings , however, are confu sing. On the one hand , the inves tigators used minimally significant increases in skin edema or suppression of contact hypersensitivity (CHS) to de fin e minimal inflammatory (MID) and minimal immunosuppressive doses (MISD) (p < 0.05). In both unprotected and 2-EHMC-protected mice , the MID and MISD w ere th e same and w ere determined to be 773 mj / cm 2 and 3091m]/cm 2 , respectively. On the other hand, the comparison of protective effects of UVB sunscreens showed that 2-EHMC-treated mice exposed to 2.8 MID (2184 mjlcm 2 ) showed significant suppression of CHS (33%) when compared to unirradiated and untrea ted controls (p < 0.05). Dose-reponse studies with 2-EI-IMC, however, showed that irradiation with about 2150 mj /cm 2 res ulted in less th an 10% suppression ofCHS. W e recently condu cted a study regarding the protective potency of UVB suns creen against solar-simulated radiation (SSR)-i.nduced immunosuppression in which we determined immunologica lly relevant end points within the epidermis and skin-draining lymph nodes. '· 2 On 6 consecutive days, h airless C3H mice (n = 5) were irradiated with SS. R (Mutzhas Supersun 5000 UV lamp equipped with a special filter system , 290 nm < A < 400 nm) with or without sunscreen protection (CO LIP A stand ard P1 [2. 7' Yc, octyl-methm.:-ycinnamate] vers11s p lacebo). On days 6-9, mice w e re topi ca il y exposed to th e mode l contact allergen, oxazolone, on the dorsal surfa ce of both ears to induce a primary CHS response. On day 10, ears and local draining lymph nodes were removed to assess lymph node ceil proliferation and activation of antigen-presenting cells, T ceils, and B cells in epidermal and lymph node ceil (LNC ) suspensions. Moreover, SSR-induced inflammation was assessed by Manuscript received March 10, 1997; revised March 13, 1997; accepted for publication Apri l 30, 1997.
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2 H omey B, Aren s A, Neubert T , Schuppe H C, Vohr 1-IW, Ru zicka T , Lelunann P. Characterization of UV-indu ced immunosuppress ion in ep idermal and local draining lymph node cells. A rclt D crmntol R es 289 (suppl): A37, 1997 (abstr) . m eas urin g dorsal doubl e skinfold tluckness. T h e results o btained showed that the murin e SPF of3.7, based on skin edema, correlated well with a human SPF of 4, w hich was determin ed by skin erythema m eas urement. Dose-response studies with unprotected or place bo-treated animals revealed that the MISD was comparabl e with 80% of the MIDun pmrccrcd· MJSD" and MID b were determined as minimal significant "s uppression of i11 JJ i JJo lymph node ceil proliferation or bi11crease in dorsal skin ed ema . Flowcytom etric analysis of epidermal cell and LNC suspensions showed that contact al le rg en-indu ced upregulation of co-stimulatory mo lec ules, such as B7-1 and inter cellular adh esion mol ec ule-1, on I-A + e pid ermal cells and LNC was m arke dl y r e du ced after irradiation with 60% of the MID unprurccrcd• whereas inftltration of CD4 + cells into the e pid ermis was initi ally suppressed after exposure to 1 MIDuup.-o rccrcd· Moreover, oxazolone-induced upreg ulation of the inte rl e ukin-2-re ceptor a -c hain (CD2 5) on CD4 + LNC was m au1tain e d up to irradiation with 1.5 MIDuupcorccrcd· ln comparison, UVB sunscreen-protected mice exhibite d a MISD of 60% of th e M!D p.-orcctcd· Furthermore, this SSR dos e dramati call y suppresse d co-stimulatory molecule expression on epide rmal cells and LN C and T -ce ll mig ration into th e e pide rmi s.
In r ecent yea rs, severa l studies have been performed rega rding protectiv e pote ncy of sunscreen s aga inst UV -u1duce d immunosuppression , and contrasting r es ults have b een publish ed (Wolf et a/, 1993; Bestak eta/ , 199 5, Rob erts and Beasley, 1 99 5). So far, it is widely accepted that the ability of sunscreens to provide immunoprotection d ep e nds criticall y on the dos e of UV radiation and can b e overcome at high UV ra diation doses. Furthermore, the spectrum of the li ght sow·ce is important u1 evaluating suns cre e n efl:l cacy for any end point b eca u se of the high sen sitivity of biologi c e ffe c ts of UVR to smail ch an ges at certain wavel ength s.
ln conclusion, w e agree with the investigators that dos e-response curves for murine ed ema and human erythema are similar, although differ ent li g ht so urces were us ed . Moreover, our fmdings confirm that UVB sunscreens protect only partially against UV-induced inununosuppression and th at subedem al doses of UV radiation were able to indu ce substantial it!Ulmosuppression . In con trast to Walker and Young's fmding that UVB SPFs against UV-induced murine ed ema and in1munosuppression are th e sa1ue, data from our stud y showed that the SPF against SSR-u1duced unmunosuppression was lower than the one against u1.fl ammation . Difl:"e ren ces between o u.r findu1 gs and thos e ofWalker and Young mi ght b e du e to tl1 e use of diKerent li ght sources (monochromatic UVB JJersus SSR) and different end points. T h ese contrasting results support th e conce pt that UVA radiation plays a critical rol e in UV-induced immunosuppression. In our opinion , the use of SSR and the assessment of immunologi call y relevant end po ults su ch as i11 JJiJJo lymph node cell proliferation and analysis of the activation of antigen-presenting cells (1-A + /CD80 [B7-1] + , 1-A + /CD54[intercellular adhesion molecule-1] +) , T (CD4 + /CD25 +) , and B (I-A + I CD45R[B220] + ) ceils in skin and sk.iJ1 -draining lymph nodes durin g primary CHS responses, m ay be more appropriate to achieve res ults that co uld be extrapolated to humans exposed to sunlig ht. Finally, we would like to stress the conclusio n that complete immunoprotection will b e achieved only by suns creens witl1 broad-0022-202X/97/S1 0.50 • Copyright © 1997 by The Sociery for Investigative Dermatology, Inc.
band absorption spectrum and a higher SPF th an necessary for the prevention of erythema. Reply:
We thank Homey et a/ for their interest in our work. Their observations are correct. When we tested the ultraviolet B (UVB) sunscreen 2-ethylhel\.'Yl-4'-methol\.'Ycinnamate (2-EHMC) after a single challenge dose of2184 mj/cm 2 , there was a 33% suppression of the contact hypersensitivity (CI-IS) response (n = 8) as is shown in Fig 6 of our paper (Walker an d Y ow1g, 1997) . However, our dose-response studies (Fig 7) with suncreen application showed that the sa me dose resulted in about 10% suppression of CHS (n = 4) . This difference in the results (which was not significant; p = 0.2) m.ay be attributed to the smaller group size in the dose-response study; one. aberrant result with smaller sample sizes ca n significantly alter the group mean. Tlus is clear from the error bars ( ± SEM), which are larger than for the dose-response study. Furthermore, the challenge dose of 2184 mJ/cm 2 is at the base of the "exponential" part of the sigmoid dose-response curve, where small variations in UVB dose (e.g., from an imal movement) are likely to result in proportionately larger errors . Our data demonstrate tl1at there is no significant difference in the shape of the dose-response curves for immunosuppression with or without sunscreen appli.cation once we allowed for attenuation ofUVB dose by the suns creen according to its protection factor against edema. Failure to affo rd complete immunoprotection with our challenge dose of 2184 mJ/cm 2 was due to a low er dose threshold for UVB-induced immunosuppresion compared with edema, despite similar protection factors for both end points. Our data emphasize the importance of dose-response studies ratl1er tl1a11 reliance on an arbitrary challenge dose of UV radiation (UVR), as is commonly done by some investigators. Homey et al have tested the protection afforded by the same UVB sunscreen [sun protection factor (SPF) = 4] against solar simulated radiation-induced immunosuppression using by six successive ex-THE JOUL~NAL OF I NVESTIGATIVE DERMATOLOGY posures to solar-stim ul ated radiation (SSR) (Mutzhas Supersun 5000) . They confirm our observations that murine edema is a good model for human erythema and that the dose threshold for UVR-induced immunosuppression (using different end poin ts) is lower than that for inflammation. In contrast to our data, th ey report that protection against immunosuppression is lower than that for inflarnmation. W e look forward to the publication of their studies, but in the meantime it is difficult to make a comment without a more detailed account of their experimental protocol than is given in their abstracts. However, they have assessed the SPF for immunoprotection after multiple SSR exposures, which cannot be readily compared with the presumed more conventional assessment of inflammation after a single exposure . For example, it is possible that multiple suhedernal doses ofUVB m ay cumulatively induce significant immunosuppression, as other workers have demonstrated that immunosuppression (suppression ofCHS) in the mouse is independent of dose fractionation (Noonan et a/, 1981 ) . T hus we cannot agree with Homey el a/ that the lower SPF for immunosuppression necessarily indicates that UV A plays a critical role in immunosuppression .
Homey et al correctly state the importance of using SSR. However, the emission spectrum of the M.utzhas Supersun source that they used is a rather poor simulation of solar UVR (a continuum), as it contains several high-inte nsity monchromatic spilces. W e would like to stress that we chose an esse ntially monochromatic UVB source (PluJips TL01 tubes) so that the abso rption spectra of the UVB sunscreens we used completely overlapped the emission spectrum of the source. This ensured that the observed su ppression ofCHS was not due to UVR w avelengths transmitted by the sunscreen . Our aim was to study the reported apparent la ck of correlation between sunscreen photoprotection of inflammation and immunosuppression. The use of a monochromatic source eliminated any confounding factors due to possible differences i11 the action spectra of edema an d immunosupression .
Sunscreens are routinely evaluated by their ability to prevent erythema from a. single SSR exposure. lf we are to determine the role of sunscreen photoprotection against solar UVR-induced immunosuppression, we must determine the relationships between SSR-induced erythema and immunosuppression in humans . Furthermore, it is also important to esta blish the effect of chroni c su berythemal SSR exposure o n the induction of both these end points . We do agree with Ruzicka et al, however, that incomplete immunoprotection requires a lugher SPF than is necessary for the prevention of erythema . T his holds true when the dose threshold for immunosuppression is lower than that for erythema even if, as demonstrated by us, the protection end points are the same.
